
4.87 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 3.83 Today|||52-Week Range 19.46 | -46.83% Year-to-Date |
Wall Street Analysts See a 426% Upside in Altimmune, Inc. (ALT): Can the Stock Really Move This High? May 23 / Zacks.com - Paid Partner Content |
Previous close | 4.62 |
Today’s open | 4.62 |
Day’s range | 4.62 - 4.94 |
Volume | 38,815 |
Average volume (3 months) | 807,446 |
Market cap | $206.2M |
Earnings growth (last year) | -22.94% |
Earnings growth (this year) | +4.32% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -46.12% |
P/E ratio | NM |
Price/Sales | 85.74 |
Price/Book | 1.04 |
Today’s change | Today’s % change | |
---|---|---|
KMDAKamada Ltd | +0.08 | +1.90% |
JNCEJounce Therapeutics ... | +0.08 | +2.19% |
XOMAXOMA Corp | +0.84 | +4.89% |
LCTXLineage Cell Therape... | +0.04 | +3.28% |
Next reporting date | August 16, 2022 |
EPS forecast (this quarter) | -$0.48 |
Annual revenue (last year) | $4.4M |
Annual profit (last year) | -$97.1M |
Net profit margin | -2,201.43% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |